AzTrials
AzTrials

Autism Spectrum DisorderNCT05340608

Development and Validation of a System for the Anticipation of Challenging Behaviors

An observational study of Autism Spectrum Disorder, run by Ariel University at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Most people with autism spectrum disorder (ASD) present at least one form of challenging behavior (CB). Self-injurious, aggressive, and disruptive CBs linked with social interaction, community-based service exclusion, and a life quality reduction for people with ASD, their caregivers, and health professionals. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Smart, non-invasive shirt - Physiological parameters, Smart, non-invasive shirt - Relation with challenging behaviors and Smart, non-invasive shirt - Proof of Concept
How many people
51 participants
Where
1 siteIsrael
Study dates
1 Jun 2022to 30 Sep 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The participants in the Observation Groups (One and Two) and Proof of Concept will be recruited from the Israeli adult population with Autism Spectrum Disorder through.

Who may be able to join

  • diagnosis of High Functioning Autism Spectrum Disorder;
  • age between 20 and 40 years.
  • diagnosis of Autism Spectrum Disorder;
  • frequent emission of aggressive and disruptive challenging behaviors (at least three times per week);
  • age between 20 and 40 years.
  • diagnosis of Autism Spectrum Disorder;
Show all 9Show fewer
  • frequent emission of aggressive and disruptive challenging behaviors (at least three times per week);
  • attending a special school for at least eight hours a day;
  • age between 20 and 40 years.

Who cannot join

  • the presence of heart disease;
  • comorbidity with other neurodevelopmental disorders.
  • the presence of heart disease;
  • comorbidity with other neurodevelopmental disorders.
  • the presence of heart disease;
  • comorbidity with other neurodevelopmental disorders.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Ariel University

    Ariel, 4070000

Other trials in Israel

About this study

Official title: Development and Validation of a System for the Anticipation of Challenging Behaviors of People With Autism Spectrum Disorder Based on a Smart Shirt: a Mixed-method Design

Most people with autism spectrum disorder (ASD) present at least one form of challenging behavior (CB). Self-injurious, aggressive, and disruptive CBs linked with social interaction, community-based service exclusion, and a life quality reduction for people with ASD, their caregivers, and health professionals. The current study has three objectives: 1) to assess the differences in the physiological reaction of high-functioning adults with ASD and typically developed peers, using bio-signal measurements such as heart rate derived from wearable Smart Shirt (SS), 2) to learn which physiological parameters can best predict the imminent onset of a CB, and 3) to develop a system able to predict the incoming occurrence of a CB in real-time and inform the caregiver through an alert notification sent on a smartphone application.

Methods and analysis: comparison between physiological parameters will carry out with two groups of 20 participants with and without ASD. Each participant will be asked to watch two five-minute videos while wearing the SS: one showing relaxing images and the other impressive human body deformities. To identify the matching between the physiological parameters variation collected by the SS and the CBs, ten participants with ASD and aggressive or disruptive CBs will be recruited. Each of these participants will wear the SS for seven consecutive days during waking hours, performing their usual daily activities. During the same seven days, the caregivers who care for the participant will fill a behavioral diary with the participant's status, reporting the times of the day in which he is quiet, agitated and the occurrence of CBs. A learning algorithm capable of predicting immediate CBs occurrence based on physiological parameter variations will be developed together with an ad hoc smartphone application. If the algorithm detects the possibility of an incoming CB, a notification will be sent to the caregiver's smartphone to inform of the possible advent of a CB, therefore enabling the implementation of the selected intervention strategy. After developing the algorithm and related smartphone application, a system efficiency proof of concept (POC) will be carried out with one participant with ASD and CB for seven days in a special school setting with healthcare professionals and teachers. A focus group including health professionals will be conducted after the POC to identify the strengths and weaknesses of the developed system.

Read the detailed description

Study goals

The current protocol consists of three phases, each with a specific goal. The first aim is to assess the differences in physiological reaction measured with a Smart Wearable Shirt (SWS) between adults with high-functioning Autism Spectrum Disorder (ASD) and typically developed peers. The second goal is to learn which physiological parameters can best predict the imminent onset of a Challenging Behavior (CB). The third aim is to develop a system able to predict the incoming occurrence of a CB in real-time and inform the caregiver through an alert notification sent on a smartphone application.

Study design

An observational study design will be implemented in the first two phases of the current research. In phase one, participants' physiological reactions to two visual stimuli will be collected and analyzed. In phase two, the physiological characteristics of CBs presented by people with ASD will be collected. A single case study with a mixed-method design will be implemented in phase three, where the system validity proof of concept will be performed.

Ethics and safety issues

The research proposal was approved by the Ariel University institutional review board (AU-HEA-ML-20201203). The study will be carried out following the Declaration of Helsinki principles. At the recruitment, written informed consent will be collected from all participants or their legal guardians. The SWS planned to use in the current protocol is a non-invasive medical device. However, if a participant does not tolerate SWS, he can withdraw from the study at any time without any repercussions.

Participants

According to a sample size calculation analysis, a group of 20 subjects diagnosed with high functioning ASD aged between 20 and 40 years residing at home (observation group - OG) along with an age and sex-matched control group (CG) of 20 typical developed peers will be enrolled in the first protocol phase. For the study's second phase, 10 people with ASD presenting aggressive or disruptive CBs aged between 20 and 40 years and their caregivers will be recruited. Finally, one participant with ASD, aged between 20 and 40 years attending a special school and living at home, which exhibits aggressive or disruptive CBs, will participate in the third phase of the research.

Procedure

Phase one - comparison between people with and without ASD physiological outcomes.

For the first phase of the current protocol, the physiological parameters of the people in the OG and CG will be acquired using the SWS while participants watch two five-minute videos. One video will show relaxing images and will emit relaxing music (relaxing video). The second video will present impressive human body deformities accompanied by anxious music (disturbing video). Both videos will be presented to the participant in a sitting position. Before starting the relaxing video, the participant will be invited to relax and lean back onto the chair's backrest. The participant can close his eyes or keep them open at his discretion to promote relaxation. Participants will be asked not to lean against the chair backrest and keep their eyes open for the duration of the disturbing video watching. The first video watched by each participant will be chosen randomly between the two videos. The duration of the entire session will be approximately 15 minutes.

Phase two - Classify the physiological parameters' variations in people with ASD.

Each participant enrolled in phase two of the protocol will wear the SWS for seven consecutive days during waking hours, performing his usual daily activities. During the same seven days, the caregivers who care for the participant will report the participant's status in the behavioral diary. Each evening, data collected by the SWS will be uploaded to an online cloud along with the behavioral diary of the day. Once the data from all the 10 participants have been collected, a Deep Learning (DL) algorithm will be developed to learn the variations in the individual's physiological parameters that occur before a CB and predict future CB. Moreover, a smartphone application will be developed to receive the SWS data in real-time and send it to a remote server where it is analyzed through the developed algorithm and the classified CB events will be extracted and presented on the applications' notification screen. In other words: if the algorithm detects the possibility of an incoming CB, a notification is sent to the caregiver's smartphone to inform of the possible advent of a CB, therefore enabling the implementation of the selected intervention strategy.

Phase three - System proof of concept.

For one week, the developed system prototype and its efficacy will be tested on one participant with ASD for seven days with healthcare professionals and teachers in a special school setting. The participant will wear the SWS during all hours of attendance at the special school. At the end of the seven days, the QUEST 2.0 will be administered to each professional and teacher who will interact with the system, and a focus group will be carried out with them to address the research questions mentioned above. The focus group will aim to answer the following research questions:

  • Did wearing the smart-shirt upset the participants?
  • Was the system able to detect all relevant CB?
  • Was the system operation speed sufficient to allow the in-time application of appropriate prevention strategies?
  • Has the use of the system reduced the amount of CB?
  • What improvements can be applied to the system to increase its effectiveness?

Information obtained from the QUEST 2.0 administration will be discussed within the focus group. In the last part of the focus group, a summation of solutions to each research question will be proposed to the group, and the number of participants that agree or disagree with the proposed summation answers will be collected.

Data analyses

Phase one

Data collected by the SWS from participants in the OG and CG will be analyzed and compared. From ECG received data, heart rate (HR) will be calculated between two consecutive QRS complexes. Considering the time interval between two QRS complexes as "t", the corresponding temporal HR will be 60/t. A percentage threshold value will be set using the sliding window method, and the minimum allowed peak width will be identified to remove unwanted artifacts from HR. The removal process will be performed for positive and negative peaks in two rounds. A window will be slid over the HR signal, and its median value will be calculated. The maximum (positive and negative) allowed peak amplitude will be determined for every window by multiplying the window's median value for a threshold value. The threshold value for positive peaks was set at 30% (for the first removal round) and 25% (for the second removal round) of the window's mean value. The threshold value was set for negative peaks at 50% (for the first removal round) and 30% (for the second removal round) of the window's mean value. Then, all peaks with amplitude bigger than the allowed value will be identified from every window. If one of these peaks is narrower than the minimum allowed peak width, it will be replaced with the reference window median value. Otherwise, if an identified peak width is bigger than the allowed peak width, its value will be replaced with the maximal allowed HR (for positive peaks) or the minimal allowed HR (for negative peaks). The maximal allowed HR will be calculated with the following formula: "209-(0.7×(Participant age))". The minimal allowed HR will be 60 bpm. After removing abnormal peaks, the signal will be filtered with a Gaussian filter with a sigma equal to 1. After the HR signal filtering process, the obtained cleaned HR signal will be used to classify the participant stress within the following levels: "no stress", "mild stress", "moderate stress", and "high stress". Each stress level will refer to an HR signal positioned within a specific range of values. The "no stress" level will include the HR values below 90% of the cleaned HR signal's lowest peak. If this HR value is lower than The "high stress" level will comprise values above 90% of the cleaned HR signal's highest peak. If this value is above the maximal allowed HR, it is substituted with 90% of the maximal allowed HR value. The range left between these two thresholds will be divided into two equal parts (lower and upper half). The HR data positioned in the lower half of this range will be classified as "mild stress" and those positioned in the upper half as "moderate stress". Each HR value will be classified and assigned with a numerical value corresponding to a stress level ("no stress" = 0, "mild stress" = 1, "moderate stress" = 2, and "high stress" = 3). After acquiring the sequences of the stress levels of all participants of Phase one, the sequences of the subjects in the OG and CG will be compared using a version of the Smith-Waterman algorithm adapted for the analysis of the obtained data.

Phase two

The data gathered by the SWS from participants enrolled in phase two will be analyzed as described above, and a DL algorithm will be developed in order to predict the incoming participants' stress levels. To find CBs patterns among subjects, a classifier based on supervised learning to find anomalies in the subject's data that might indicate on CB that is about to occur will be constructed. A long-short term memory (LSTM) algorithm will be taught to recognize data patterns corresponding to CBs occurrence using the data collected by the participants' caregivers through the behavioral diary and the information collected in Phase one. LSTM is an extension of the recurrent neural network (RNN). In contrast to other applications of Machine Learning (ML) and DL, in the process of analyzing and predicting time-series information, each data point is based on previous information, which must be examined as well. RNN is the most used network for time series applications since it can form the target vector by observing the current input data history, using shared wights among the hiding units of the network across each time step of the data. The authors choose LSTM, not the RNN, because RNN has a significant vanishing gradient problem. The gradient of output error is based on previous inputs vanishes when time lags between inputs and errors increase. To overcome this problem, the LSTM is introduced. LSTM has a memory, which comes to practice by replacing the nonlinear units of RNN in the hidden layers with memory blocks. The network propagates errors throughout the entire network, and as a result, it can learn long-term dependencies and forget unnecessary information based on the data at hand. The accuracy of the prediction model will be calculated according to standard estimation methods such as the confusion matrix and the area under the curve (AUC) Values. These values range from 0.5 to 1, with 1 being perfect classification and 0.5 being no better than luck.

Phase three

The themes that will emerge from the focus group will be extracted from the discussion transcription. Axial coding strategy will be applied to calculate the extensiveness of each theme discussion. This qualitative data analysis consists of assigning a reference number to each theme and then marking any sentence related to that theme with that number. A reliability check for the code-to-sentence matches will be applied by giving the list of codes to an independent researcher experienced in qualitative analysis and asking him to identify the sentence that matches each code. The level of agreement to summation answers to the research questions will be obtained by calculating the percentage of participants that agree with the proposed statement. The authors will discuss the developed answers in the light of the relevant emerged themes and the level of agreement of the discussion group.

Being tested
Smart, non-invasive shirt - Physiological parameters, Smart, non-invasive shirt - Relation with challenging behaviors, Smart, non-invasive shirt - Proof of Concept
Keywords
Autism Spectrum Disorder, Problem Behavior, Aggression, Self-Injurious Behavior, Telemedicine, Accident Prevention
Medical subject headings
Autism Spectrum Disorder, Problem Behavior, Aggression, Self-Injurious Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart, non-invasive shirt - Physiological parametersOther

    Also called Hexoskin Smart Garments

    Observation Group One and Control Group - Participants in these groups will be asked to wear a smart, non-invasive shirt while watching two different five-minute videos. One video will show relaxing images and will emit relaxing music (relaxing video). The second video will present impressive human body deformities accompanied by anxious music (disturbing video). Both videos will be presented with the participant in a sitting position. The duration of the entire session will be approximately 15 minutes. For the whole duration of the session, the smart shirt will collect data on participants' physiological parameters (electrocardiogram, heart rate, heart rate variability, respiration rate, minute ventilation, and body movement). Collected data will be used to develop an ad-hoc algorithm to anticipate the challenging behavior of participants with autism spectrum disorder based on physiological data collected by the smart shirt.

  • Smart, non-invasive shirt - Relation with challenging behaviorsOther

    Also called Hexoskin Smart Garments

    Observation Group Two - Each participant in this group will be asked to wear the smart, non-invasive shirt for seven consecutive days during waking hours, performing his usual daily activities. During the same seven days, the caregivers who care for the participant will be asked to accurately report the participant's status in a behavioral diary. Each evening, the data collected by the smart shirt will be uploaded to an online cloud along with the behavioral diary of the day. Collected data will be used to develop an ad-hoc algorithm able to anticipate the challenging behavior of participants with autism spectrum disorder based on physiological data collected by the smart shirt.

  • Smart, non-invasive shirt - Proof of ConceptOther

    Also called Hexoskin Smart Garments

    Proof of Concept - The participant with autism spectrum disorder enrolled in the proof-of-concept phase of this study will wear the smart, non-invasive shirt for seven days during all hours of attendance at the special school. At the end of the seven days, the healthcare professional and teacher who interacted with the developed system at the special school will participate in a focus group to analyze their experiences and opinions related to the system use.

Study groups in NCT05340608
Study groupRoleWhat they receive
Observation Group OneTwenty subjects with high functioning autism spectrum disorder, aged between 20 and 40 years, residing at home.
Receives: Other: Smart, non-invasive shirt - Physiological parameters
Control GroupTwenty typically-developed subjects matched for sex and age distribution with participants in the Observation Group One.
Receives: Other: Smart, non-invasive shirt - Physiological parameters
Observation Group TwoThis group will include ten people with autism spectrum disorders, aged between 20 and 40 years, residing at home and presenting aggressive or disruptive challenging behaviors, and their caregivers.
Receives: Other: Smart, non-invasive shirt - Relation with challenging behaviors
Proof of ConceptOne participant with autism spectrum disorder, aged between 20 and 40 years attending a special school and living at home and exhibiting aggressive or disruptive challenging behavior, and healthcare professionals and teachers who care for him in the school setting, will participate in the proof-of-concept phase of the present study.
Receives: Other: Smart, non-invasive shirt - Proof of Concept

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate - Phase one (1)

    Electrocardiogram (ECG) will be collected through a 1-lead electrocardiograph (256 Hz - 12 bits - Resolution LSB: 0.0064 mV). Heart rate (HR) will be calculated from the obtained ECG between two consecutive QRS complexes. Considering the time interval between two QRS complexes as "t", the corresponding temporal HR will be 60/t. ECG will be collected within the study Phase one while the participants watch a five-minute relaxing video.

    Measured: Five-minute during the study Phase one.

  2. Heart rate - Phase one (2)

    Electrocardiogram (ECG) will be collected through a 1-lead electrocardiograph (256 Hz - 12 bits - Resolution LSB: 0.0064 mV). Heart rate (HR) will be calculated from the obtained ECG between two consecutive QRS complexes. Considering the time interval between two QRS complexes as "t", the corresponding temporal HR will be 60/t. ECG will be collected within the study Phase one while the participants watch a five-minute disturbing video.

    Measured: Five-minute during the study Phase one.

  3. Heart rate - Phase two

    Electrocardiogram (ECG) will be collected through a 1-lead electrocardiograph (256 Hz - 12 bits - Resolution LSB: 0.0064 mV). Heart rate (HR) will be calculated from the obtained ECG between two consecutive QRS complexes. Considering the time interval between two QRS complexes as "t", the corresponding temporal HR will be 60/t. ECG will be collected within the study Phase two during the participants' waking hours.

    Measured: Seven consecutive days during study Phase two.

  4. Heart rate - Phase three

    Electrocardiogram (ECG) will be collected through a 1-lead electrocardiograph (256 Hz - 12 bits - Resolution LSB: 0.0064 mV). Heart rate (HR) will be calculated from the obtained ECG between two consecutive QRS complexes. Considering the time interval between two QRS complexes as "t", the corresponding temporal HR will be 60/t. ECG will be collected within the study Phase three during the participant's attendance at special school.

    Measured: Seven consecutive days during study Phase three.

  5. Behavioral Diary

    Participant's arousal level reported by participant's caregivers. Three arousal level will be reported: "Quiet", "Agitated", and "Challenging Behavior". The participants' behavioral diary will be collected within the study Phase two.

    Measured: Seven consecutive days during study Phase two.

  6. Quebec User Evaluation of Satisfaction with Assistive Technology second edition (QUEST 2.0)

    It is a 12-item questionnaire designed to assess users' satisfaction with a wide range of assistive technology. It will be administered to healthcare professionals and teachers who interacted with the system at the participant's special school.

    Measured: Phase three, at the end of the seven-day proof of concept trial - one administration.

  7. Focus Group

    It is a technique to produce a controlled discussion on specific issues within a group of people that share different relations with the focused topics. It will be conducted with the researcher and the healthcare professionals and teachers who interacted with the system at the participant's special school to answer the following research questions: a) Did wearing the SWS upset the participants? b) Was the system able to detect all relevant CB? c) Did having been informed of the occurrence of CB allow the in-time application of appropriate prevention strategies? d) Has the use of the system reduced the amount of CB? e) What improvements can be applied to the system to increase its effectiveness?

    Measured: Phase three, at the end of the seven-day proof of concept trial - one three-hour session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2022
  2. Study start1 Jun 2022
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05340608
Sponsor's protocol ID
AU-HEA-ML-20201203
Other IDs
72359
Status last verified
Dec 2022
First submitted
9 Apr 2022
Last updated
30 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry. 2009 Jun;194(6):500-9. doi: 10.1192/bjp.bp.108.059345.

    PubMed 19478287
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington (DC): American Psychiatric Association; 2013.

  • Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009 May;13(3):317-36. doi: 10.1177/1362361309104246.

    PubMed 19369391
  • Arnold S, Reed P. Reading assessments for students with ASD: a survey of summative reading assessments used in special educational schools in the UK. Br J Spec Educ. 2016;43(2):122-141.

  • Chiang HM. Expressive communication of children with autism: the use of challenging behaviour. J Intellect Disabil Res. 2008 Nov;52(11):966-72. doi: 10.1111/j.1365-2788.2008.01042.x. Epub 2008 Jan 18.

    PubMed 18205752
  • O'Donnell S, Deitz J, Kartin D, Nalty T, Dawson G. Sensory processing, problem behavior, adaptive behavior, and cognition in preschool children with autism spectrum disorders. Am J Occup Ther. 2012 Sep-Oct;66(5):586-94. doi: 10.5014/ajot.2012.004168.

    PubMed 22917125
  • Baker AE, Lane A, Angley MT, Young RL. The relationship between sensory processing patterns and behavioural responsiveness in autistic disorder: a pilot study. J Autism Dev Disord. 2008 May;38(5):867-75. doi: 10.1007/s10803-007-0459-0.

    PubMed 17899349
  • Murphy GH, Beadle-Brown J, Wing L, Gould J, Shah A, Holmes N. Chronicity of challenging behaviours in people with severe intellectual disabilities and/or autism: a total population sample. J Autism Dev Disord. 2005 Aug;35(4):405-18. doi: 10.1007/s10803-005-5030-2.

    PubMed 16134027
  • Prizant BM, Wetherby AM. Critical Issues in Enhancing Communication Abilities for Persons with Autism Spectrum Disorders. In: Volkmar FR, Paul R, Klin A, Cohen D, editors. Handbook of Autism and Pervasive Developmental Disorders. Hoboken, NJ. John Wiley & Sons, Inc.; 2005. p. 925-945.

  • Reese RM, Richman DM, Belmont JM, Morse P. Functional characteristics of disruptive behavior in developmentally disabled children with and without autism. J Autism Dev Disord. 2005 Aug;35(4):419-28. doi: 10.1007/s10803-005-5032-0.

    PubMed 16134028
  • Emerson E. Challenging behaviour: Analysis and intervention in people with severe intellectual disabilities. 2nd ed. Cambridge: Cambridge University Press; 2001.

  • Holden B, Gitlesen JP. A total population study of challenging behaviour in the county of Hedmark, Norway: prevalence, and risk markers. Res Dev Disabil. 2006 Jul-Aug;27(4):456-65. doi: 10.1016/j.ridd.2005.06.001. Epub 2005 Aug 30.

    PubMed 16137857
  • Jang J, Dixon DR, Tarbox J, Granpeesheh D. Symptom severity and challenging behavior in children with ASD. Res Autism Spectr Disord. 2011;5(3):1028-1032. doi: 10.1016/j.rasd.2010.11.008.

  • Matson JL, Wilkins J, Macken J. The relationship of challenging behaviors to severity and symptoms of autism spectrum disorders. J Ment Health Res Intellect Disabil. 2008;2(1):29-44. doi:10.1080/19315860802611415.

  • Murphy O, Healy O, Leader G. Risk factors for challenging behaviors among 157 children with autism spectrum disorder in Ireland. Res Autism Spectr Disord. 2009;3(2):474-482. doi:10.1016/j.rasd.2008.09.008.

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder, run by Ariel University at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate - Phase one (1) (time frame: Five-minute during the study Phase one.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05340608, which also lists 116 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in